PMS2 and Lynch syndrome: According to revised Bethesda criteria and germline mutation confirmation (25), 57 patients (21.8%) were Lynch syndrome, and dMMR occurred in 148 patients (64.6%) in MLH1-PMS2 complex, 68 (29.7%) in MSH2-MSH6 complex and 13 (5.7%) in both.